A Randomized Trial Comparing Seven-Day Ranitidine Bismuth Citrate and Clarithromycin Dual Therapy to Seven-Day Omeprazole, Clarithromycin and Amoxicillin Triple Therapy for the Eradication of Helicobacter pylori
OBJECTIVE: To assess Helicobacter pylori eradication after one week dual ranitidine bismuth citrate-clarithromycin (RBC-C) or triple omeprazole, clarithromycin and amoxicillin (OCA) therapy.
Saved in:
Main Authors: | Sander Veldhuyzen van Zanten, Naoki Chiba, Alan Barkun, Carlo Fallone, Alain Farley, Alan Cockeram, Chrystian Dallaire, Lorinda Simms, Barbara Nicholls |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2003-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2003/425293 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clarithromycin crystalluria
by: Zhao Weihua, et al.
Published: (2025-02-01) -
Pyrosequencing Assay to Rapidly Detect Clarithromycin Resistance Mutations in Canadian Helicobacter pylori Isolates
by: R Slinger, et al.
Published: (2009-01-01) -
Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
by: K Lauritsen, et al.
Published: (1999-01-01) -
Potentiation of Doxorubicin Cytotoxicity Utilizing Clarithromycin
Loaded-PEGylated Liposomes
by: Islam Alfreahat MS, et al.
Published: (2025-01-01) -
Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease
by: Alexander L. Pukhalsky, et al.
Published: (2004-01-01)